IMAB Valuation

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

IMAB Relative Valuation

IMAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IMAB is overvalued; if below, it's undervalued.

Historical Valuation

I-Mab (IMAB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 15.85. The fair price of I-Mab (IMAB) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：0.67

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.27

P/B

Median3y

0.64

Median5y

2.60

-95.94

FCF Yield

Median3y

-18.75

Median5y

-12.43

Competitors Valuation Multiple

The average P/S ratio for IMAB's competitors is 138.97, providing a benchmark for relative valuation. I-Mab Corp (IMAB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap